OMC
37
-2
NI
62
-3
PBI
58
-8
GOOGL
66
-6
DVN
22
-2
DHI
39
8
CNP
50
-9
NUE
37
-3
GRMN
56
-3
STT
50
-7
VNO
52
-4
TSN
23
-3
HP
48
-5
EXR
42
9
PPL
37
-2
LNC
29
-4
PPG
58
-2
WMB
55
-4
ROP
51
-5
ALL
37
-3
OMC
37
-2
NI
62
-3
PBI
58
-8
GOOGL
66
-6
DVN
22
-2
DHI
39
8
CNP
50
-9
NUE
37
-3
GRMN
56
-3
STT
50
-7
VNO
52
-4
TSN
23
-3
HP
48
-5
EXR
42
9
PPL
37
-2
LNC
29
-4
PPG
58
-2
WMB
55
-4
ROP
51
-5
ALL
37
-3
Financhill
Back

Enlivex Therapeutics 10K Form

Sell
37

ENLV
Enlivex Therapeutics

Last Price:
1.19
Seasonality Move:
14.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENLV News And Ratings

See the #1 stock for the next 7 days that we like better than ENLV

ENLV Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-2.63M
Price / Cash Flow: 0
Annual Sales: $1.21
Price / Book: 0.98

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-18.93M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Enlivex Therapeutics Earnings Forecast

Key Enlivex Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

Enlivex Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ENLV
CUSIP: M4130Y
Website: enlivex.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ENLV Technical Analysis vs Fundamental Analysis

Sell
37
Enlivex Therapeutics (ENLV) is a Sell

Is Enlivex Therapeutics a Buy or a Sell?